NewsRx

Search our medical news database

Cervical Cancer

Diamics, Inc.'s Proprietary Cervical Cancer Screening System To Be Presented At Aacc Clinical Lab Expo

Published in Cancer Weekly, June 12th, 2007

Diamics, Inc., a San Francisco Bay-area, medical device and diagnostics company, today announced it will present several scientific posters at the annual American Association for Clinical Chemistry (AACC) meeting describing the company's proprietary cervical cancer screening system. The posters will be on display at the Diamics exhibit (#2466).

The system, called C-MAP, is designed to be a faster, less expensive and more accurate way to screen for cervical cancer than Pap tests and other current screening approaches. It examines the behavior of groups of cells within discrete areas of the cervix, allowing lesions to be effectively analyzed in situ. Because results are...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook